Company updateMoneycontrol
Wockhardt plans US Zaynich launch via publications
Positive+39
GreyOak summary
The company chose to market the drug directly rather than out-license it.
What it affects
- WockhardtWOCKPHARMAPositive +39
Preparing US launch with scientific publications.Rolling sentiment Positive +15
Source
Read the original at MoneycontrolMore Wockhardt news
No other recent stories about Wockhardt.
All Wockhardt news →